BioXcel Therapeutics, Inc. (BTAI) NASDAQ
1.43
-0.04(-2.72%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.43
-0.04(-2.72%)
Currency In USD
| Market Cap | 15.16M |
| Enterprise Value | 88.25M |
| P/E Ratio | -0.3 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 46.3 |
| Price/Book Ratio | -0.23 |
| Enterprise/Revenue | 142 |
| Enterprise/EBITDA | -2.08 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | -90.71 |
| Operating Margin | -66.98 |
| Return On Assets | -1.52 |
| Return On Equity | 0.72 |
| Revenue | 2.27M |
| Revenue/Share | 0.05 |
| Gross Profit | 123,000 |
| EBITDA | -44.16M |
| Net Income | -59.6M |
| Diluted EPS | -23.51 |
| Total Cash | 37.32M |
| Total Cash/Share | 2.63 |
| Total Debt | 109.29M |
| Total Debt/Equity | -1.23 |
| Current Ratio | 1.17 |
| Book Value Per Share | -6.26 |
| 52-Week Change | -37.55 |
| 52-Week High | 8.08 |
| 52-Week Low | 1.17 |
| Moving Average 50 Days | 1.67 |
| Moving Average 200 Days | 2.28 |
| Average Volume | 1.4M |
| Shares Outstanding | 24.35M |
| % Held by Institutions | 24.91 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:16 |
| Last Split Date | February 10, 2025 |